The medicine cabinet

What's in it, why, and can we change the contents?

Thomas W. Croghan, Patricia M. Pittman

Research output: Contribution to journalArticle

Abstract

The failure of the pharmaceutical industry to produce drugs for common chronic diseases, emerging diseases, and the potential threats of bioterrorism or the spread of tropical diseases contrasts sharply with the industry's output of lifestyle and "me-too" drugs. In this paper we review the decision-making process that resulted in our current portfolio of medicines and offer several alternatives to better align business incentives with medical need.

Original languageEnglish (US)
Pages (from-to)23-33
Number of pages11
JournalHealth Affairs
Volume23
Issue number1
DOIs
StatePublished - Jan 2004
Externally publishedYes

Fingerprint

Medicine
medicine
Disease
Bioterrorism
Drug Industry
Pharmaceutical Preparations
drug
Life Style
Motivation
Decision Making
Industry
Chronic Disease
pharmaceutical industry
decision-making process
incentive
threat
industry

ASJC Scopus subject areas

  • Nursing(all)
  • Health(social science)
  • Health Professions(all)
  • Health Policy

Cite this

The medicine cabinet : What's in it, why, and can we change the contents? / Croghan, Thomas W.; Pittman, Patricia M.

In: Health Affairs, Vol. 23, No. 1, 01.2004, p. 23-33.

Research output: Contribution to journalArticle

Croghan, Thomas W. ; Pittman, Patricia M. / The medicine cabinet : What's in it, why, and can we change the contents?. In: Health Affairs. 2004 ; Vol. 23, No. 1. pp. 23-33.
@article{9e8579caaffb44b085280e7d4224d70d,
title = "The medicine cabinet: What's in it, why, and can we change the contents?",
abstract = "The failure of the pharmaceutical industry to produce drugs for common chronic diseases, emerging diseases, and the potential threats of bioterrorism or the spread of tropical diseases contrasts sharply with the industry's output of lifestyle and {"}me-too{"} drugs. In this paper we review the decision-making process that resulted in our current portfolio of medicines and offer several alternatives to better align business incentives with medical need.",
author = "Croghan, {Thomas W.} and Pittman, {Patricia M.}",
year = "2004",
month = "1",
doi = "10.1377/hlthaff.23.1.23",
language = "English (US)",
volume = "23",
pages = "23--33",
journal = "Health Affairs",
issn = "0278-2715",
publisher = "Project Hope",
number = "1",

}

TY - JOUR

T1 - The medicine cabinet

T2 - What's in it, why, and can we change the contents?

AU - Croghan, Thomas W.

AU - Pittman, Patricia M.

PY - 2004/1

Y1 - 2004/1

N2 - The failure of the pharmaceutical industry to produce drugs for common chronic diseases, emerging diseases, and the potential threats of bioterrorism or the spread of tropical diseases contrasts sharply with the industry's output of lifestyle and "me-too" drugs. In this paper we review the decision-making process that resulted in our current portfolio of medicines and offer several alternatives to better align business incentives with medical need.

AB - The failure of the pharmaceutical industry to produce drugs for common chronic diseases, emerging diseases, and the potential threats of bioterrorism or the spread of tropical diseases contrasts sharply with the industry's output of lifestyle and "me-too" drugs. In this paper we review the decision-making process that resulted in our current portfolio of medicines and offer several alternatives to better align business incentives with medical need.

UR - http://www.scopus.com/inward/record.url?scp=4243148517&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4243148517&partnerID=8YFLogxK

U2 - 10.1377/hlthaff.23.1.23

DO - 10.1377/hlthaff.23.1.23

M3 - Article

VL - 23

SP - 23

EP - 33

JO - Health Affairs

JF - Health Affairs

SN - 0278-2715

IS - 1

ER -